BridgeMD
New treatment option for Myopia
Official title Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses
ClinicalTrials.gov ID: NCT07021560
What this study is testing
- What it's testing
- This is a clinical trial evaluating the wearability and effectiveness of three types of ZEISS spectacle lenses in controlling myopia progression. This study compares ZEISS MyoCare spectacle lenses with two types of single-vision spectacle lenses over a 6-month period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 13. Healthy volunteers may be eligible.
You may be able to join if
- be accompanied by a parent or guardian who is able to read and comprehend Vietnamese/English and sign a record of informed consent/assent;
- at baseline, be within the age range of 7 to 13 years old inclusive;
- be diagnosed as myopic having cycloplegic spherical equivalent between -0.75 dioptre (D) and -5.00 dioptre (D);
- astigmatism ≤1.50D;
- anisometropia of not more than 1.50D;
You likely can't join if
- Any pre-existing systemic or ocular condition, including infection or disease that is likely to affect visual acuity and refractive error;
- Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis...
- Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant's...
- History of eye trauma or eye surgery
- Amblyopia
- Anisometropia of not more than 1.50D
See the full eligibility criteria
- be accompanied by a parent or guardian who is able to read and comprehend Vietnamese/English and sign a record of informed consent/assent;
- at baseline, be within the age range of 7 to 13 years old inclusive;
- be diagnosed as myopic having cycloplegic spherical equivalent between -0.75 dioptre (D) and -5.00 dioptre (D);
- astigmatism ≤1.50D;
- anisometropia of not more than 1.50D;
- be willing to comply with the wearing of clinical trial spectacles and clinical trial visit schedule as directed by the investigator;
- have ocular findings deemed to be normal;
- vision correctable to at least 0.8 or better in each eye with spectacles.
- Any pre-existing systemic or ocular condition, including infection or disease that is likely to affect visual acuity and refractive error;
- Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus.
- Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant's ocular health / physiology in an adverse or beneficial manner at enrolment...
- History of eye trauma or eye surgery
- Amblyopia
- Anisometropia of not more than 1.50D
- Strabismus
- History of use of myopia control interventions such as Orthokeratology or atropine 3 months prior to commencement of this trial.
- Known allergy or intolerance to ingredients to cycloplegic eye-drops.
- Currently enrolled in another clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Hanoi, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 13 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hanoi, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.